Corrigendum to “Von Willebrand factor and ADAMTS13 in arterial thrombosis: A systematic review and meta-analysis” [Blood Rev 28 (2014) 167–178]

The authors would like to make a correction in the abovementioned article. For the meta-analysis the authors used data from the previously published ATTAC study (T.N. Bongers et al., Atherosclerosis 2009, 207) on the association between ADAMTS13 levels and coronary heart disease (CHD). The originally reported OR for CHD in individuals with ADAMTS13 levels in the lowest tertile compared to individuals in the highest tertile was 8.2 (95% CI 4.5–14.7). Recently this OR was corrected to 5.20 (95% CI 2.67–10.13) after re-analysis of the data on CHD.
Source: Blood Reviews - Category: Hematology Authors: Tags: Corrigendum Source Type: research